We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RCL:NYSERoyal Caribbean Cruises Ltd. analysis

Data as of Sep 9, 2026 - not real-time

Latest price
$259.76
Risk: medium
6/10Medium risk

Summary

Royal Caribbean Cruises Ltd. is priced at $259.76, and its moving averages give no clean directional read — the structure is neutral. Over a rolling month the price has lost 19.5%. With RSI at 22.8 the momentum picture is oversold, alongside a bearish MACD signal. Watch $257.85 as support and $313.50 as the nearer resistance level.
On valuation the read is fair — an earnings multiple of 16.0, absent a reliable peer benchmark. Analyst price targets sit 33.6% above the current price. Revenue is growing at 6.5% on a 23.5% profit margin. The 2.27% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 6 — elevated. With 30-day volatility of 23.3%, a beta of 1.61 and a maximum drawdown of 29.6%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.

Top market events

  • Royal Caribbean Cruises NYSE:RCL has announced a new fixed-income offering of senior unsecured notes due 2034.
  • Royal Caribbean RCL possesses the right combination of the two key ingredients for a likely earnings beat in its...
  • Royal Caribbean Cruises Ltd. NYSE:RCL is one of the Iran Peace Deal Sends Oil Lower: Top 8 Travel Stocks to Buy Now.

Market outlook

Short term

< 1 year

Neutral

Model confidence3/103 out of 10

Key factors

  • RSI at 22.8 signals oversold conditions
  • Trading below the 200-day average of 287.93
  • MACD momentum is negative

Medium term

1–3 years

Neutral

Model confidence3/103 out of 10

Key factors

  • RSI at 22.8 signals oversold conditions
  • Trading below the 200-day average of 287.93
  • Analyst targets imply +33.6% versus the current price

Long term

> 3 years

Neutral

Model confidence3/103 out of 10

Key factors

  • Analyst targets imply +33.6% versus the current price
  • Profit margin of 23.5% is healthy
  • Negative free cash flow

Key metrics

Financial health

Revenue Growth6.50%
Profit Margin23.54%
P/E Ratio16.0
ROE44.67%
ROA7.68%
Debt/Equity224.82
P/B Ratio6.8
Op. Cash Flow$6.8B
Free Cash Flow$-1516249984

Technical analysis

TrendNeutral
RSI22.8
Support$257.85
Resistance$313.50
MA 20$284.97
MA 50$295.00
MA 200$287.93
MACDBearish
VolumeIncreasing
Fear & Greed Index92.04

Valuation

Fair Value$210.55
Target Price$346.92
Upside/Downside33.56%
GradeFair
TypeBlend
Dividend Yield2.27%

Risk assessment

Beta1.61
Volatility23.33%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.